Efficacy of continuous, daily, oral, ultra-low-dose 200 mg acyclovir to prevent herpes zoster events among bortezomib-treated patients: a report from retrospective study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples